98%
921
2 minutes
20
In this article we comment on the paper by Xu describing retrospective data on endoscopic treatment outcome of esophageal gastrointestinal stromal tumors (GISTs). Esophageal GIST is a rare type of mesenchymal tumor. GISTs originate from the interstitial cells of Cajal, which are pacemaker cells involved in gut motility. GISTs are most commonly found in the stomach and small intestine, but esophageal involvement is rare. Esophageal GISTs account for < 1% of all GISTs. Endoscopic resection remains the mainstay for small, localized tumors with excellent outcomes. However, larger tumors may require multidisciplinary strategies to provide the best oncological outcomes. Here, we discuss the usefulness of endoscopic ultrasound (EUS) of subepithelial tumors of the upper gastrointestinal tract. EUS is a crucial tool in the diagnosis, staging, and management of subepithelial masses. Given the subepithelial nature of these tumors, standard endoscopy is not adequate, making EUS essential for a comprehensive assessment. EUS provides accurate tumor size assessment and enables fine needle aspirations guided biopsy, for treatment planning.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12146910 | PMC |
http://dx.doi.org/10.3748/wjg.v31.i19.105888 | DOI Listing |
Clin Endosc
August 2025
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Endoscopic full-thickness resection (EFTR) is a minimally invasive technique that is increasingly used for gastrointestinal stromal tumors (GISTs) originating from the muscularis propria. Despite its advantages over conventional surgery, such as complete tumor resection and faster recovery, EFTR faces challenges related to its efficacy, safety, and feasibility, particularly in gastric GISTs. By summarizing the literature published over the past decade, this review provides a comprehensive overview of the clinical outcomes of EFTR and the evolution of defect closure devices.
View Article and Find Full Text PDFGastroenterol Hepatol
August 2025
Endoscopy Unit, Department of Digestive Diseases, Hospital Universitari de Bellvitge, Barcelona, Catalonia, Spain; Digestive Diseases Unit, Hospital General de Granollers, Catalonia, Spain.
J Gastrointest Cancer
August 2025
Diagnostic Center Bled Group, Pod Skalo 4, 4260, Bled, Slovenia.
Purpose: Endoscopic submucosal dissection (ESD) is a minimally invasive technique used to treat gastrointestinal neoplasms. Lower incidence of gastric lesions results in fewer studies of gastric ESD in the West. We aimed to show the safety and efficacy of gastric ESD in a non-academic center as compared to the available studies, while adhering to established international guidelines.
View Article and Find Full Text PDFVideoGIE
September 2025
Department of Gastroenterology and Advanced Endoscopy, Bharati Vidyapeeth (deemed university), Pune, Maharashtra, India.
Background And Aims: Gastric neuroendocrine tumors (NETs), although rare, are highly vascular subepithelial lesions that can pose significant bleeding risks during endoscopic submucosal dissection (ESD). Traditionally, bleeding is managed intraoperatively with mechanical or thermal hemostasis, but pre-emptive strategies remain underexplored. Here, we report the use of EUS-guided pre-emptive epinephrine injection to minimize the bleeding risk during gastric NET ESD.
View Article and Find Full Text PDFVideoGIE
September 2025
Sharp HealthCare, San Diego, California, USA.
Background And Aims: In the past, endoscopic resection of gastric subepithelial lesions (SELs) was restricted to small lesions confined to the submucosa. Larger and deeper lesions were resected surgically. Recent innovations in endoscopy have yielded multiple techniques for extending the boundaries and providing minimally invasive resection of larger and deeper lesions.
View Article and Find Full Text PDF